User: I want to come up with a SMILES.
Assistant: This sounds very exciting. Should I consider any constraints for the creation?
User: Yes, please. The molecule should have a half life in humans after IV administration value of approximately 0.570 hours.
Assistant: Ok, here you go, this SMILES has a half life in humans after IV administration value of approximately 0.570 hours: CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O
User: I want to {#come up with|create|generate!} a {#molecule |!}{SMILES__description}.
Assistant: {#This sounds very exciting. |This sounds very interesting. !}Should I consider any {#constraints|specific points!} for the {#generation|creation!}?
User: Yes, please. The molecule should have a {half_life_duration__names__noun} value of approximately {half_life_duration#} {half_life_duration__units}.
Assistant: {#Ok|Got it!},{# here you go,|!} this {SMILES__description} has a {half_life_duration__names__noun} value of approximately {half_life_duration#} {half_life_duration__units}: {SMILES#}
(5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid